Literature DB >> 14580085

Family study of the aggregation of eating disorders and mood disorders.

B Mangweth1, J I Hudson, H G Pope, A Hausmann, C De Col, N M Laird, W Beibl, M T Tsuang.   

Abstract

BACKGROUND: Family studies have suggested that eating disorders and mood disorders may coaggregate in families. To study further this question, data from a family interview study of probands with and without major depressive disorder was examined.
METHOD: A bivariate proband predictive logistic regression model was applied to data from a family interview study, conducted in Innsbruck, Austria, of probands with (N = 64) and without (N = 58) major depressive disorder, together with 330 of their first-degree relatives.
RESULTS: The estimated odds ratio (OR) for the familial aggregation of eating disorders (anorexia nervosa, bulimia nervosa and binge-eating disorder) was 7.0 (95 % CI 1.4, 28; P = 0.006); the OR for the familial aggregation of mood disorders (major depression and bipolar disorder) was 2.2 (0.92, 5.4; P = 0.076); and for the familial coaggregation of eating disorders with mood disorders the OR was 2.2 (1.1, 4.6; P = 0.035).
CONCLUSIONS: The familial coaggregation of eating disorders with mood disorders was significant and of the same magnitude as the aggregation of mood disorders alone--suggesting that eating disorders and mood disorders have common familial causal factors.

Entities:  

Mesh:

Year:  2003        PMID: 14580085     DOI: 10.1017/s0033291703008250

Source DB:  PubMed          Journal:  Psychol Med        ISSN: 0033-2917            Impact factor:   7.723


  9 in total

1.  Prevalence and correlates of eating disorder co-morbidity in patients with bipolar disorder.

Authors:  Jennifer E Wildes; Marsha D Marcus; Andrea Fagiolini
Journal:  Psychiatry Res       Date:  2008-09-07       Impact factor: 3.222

2.  The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication.

Authors:  James I Hudson; Eva Hiripi; Harrison G Pope; Ronald C Kessler
Journal:  Biol Psychiatry       Date:  2006-07-03       Impact factor: 13.382

3.  Depression, anxiety, and obsessionality in long-term recovered patients with adolescent-onset anorexia nervosa.

Authors:  K Holtkamp; B Müller; N Heussen; H Remschmidt; B Herpertz-Dahlmann
Journal:  Eur Child Adolesc Psychiatry       Date:  2005-03       Impact factor: 4.785

4.  Eating disorders in men: current features and childhood factors.

Authors:  B Mangweth-Matzek; C I Rupp; A Hausmann; S Gusmerotti; G Kemmler; W Biebl
Journal:  Eat Weight Disord       Date:  2010 Mar-Jun       Impact factor: 4.652

5.  Parental substance use history of overweight men and women with binge eating disorder is associated with distinct developmental trajectories and comorbid mood disorder.

Authors:  Kerstin K Blomquist; Robin M Masheb; Marney A White; Carlos M Grilo
Journal:  Compr Psychiatry       Date:  2011-02-05       Impact factor: 3.735

6.  Unanticipated Rapid Remission of Refractory Bulimia Nervosa, during High-Dose Repetitive Transcranial Magnetic Stimulation of the Dorsomedial Prefrontal Cortex: A Case Report.

Authors:  Jonathan Downar; Ashwin Sankar; Peter Giacobbe; Blake Woodside; Patricia Colton
Journal:  Front Psychiatry       Date:  2012-04-20       Impact factor: 4.157

7.  Bulimic behaviours and psychopathology in obese adolescents and in their parents.

Authors:  Pascale Isnard; Laure Quantin; Samuele Cortese; Bruno Falissard; Dara Musher-Eizenman; Antoine Guedeney; Marie-Laure Frelut; Marie-Christine Mouren
Journal:  Int J Pediatr Obes       Date:  2010-03-17

Review 8.  The impact of indicated prevention and early intervention on co-morbid eating disorder and depressive symptoms: a systematic review.

Authors:  Rachel F Rodgers; Susan J Paxton
Journal:  J Eat Disord       Date:  2014-11-13

9.  Systematic Review: Overlap Between Eating, Autism Spectrum, and Attention-Deficit/Hyperactivity Disorder.

Authors:  Kathrin Nickel; Simon Maier; Dominique Endres; Andreas Joos; Viktoria Maier; Ludger Tebartz van Elst; Almut Zeeck
Journal:  Front Psychiatry       Date:  2019-10-10       Impact factor: 4.157

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.